Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
To Live a Sparkly Life
It’s been a couple of months now, and I’m pleased to say I am tolerating the new drug, Carfilzomib, brand name Kyprolis, very well. I’m now on the ‘Dara’ (Daratumumab AKA Darzolex) just once a month, but I’m getting the Kyprolis 6 times every three weeks, so I am getting to know my nurses very well! The Kyprolis visits are relatively short, lasting an hour to 2 hours each time, depending on whether we are doing lab work, etc.
On the Dara day each month, the Kyprolis adds another 10 minutes onto the 5 hour visit. The Dara days are the nap days. I’m still getting nothing done, but it is incredibly relaxing as the Benedryl takes hold and I’m off to a delicious dreamland for an hour or two or three.
Source: https://toliveasparklylife.com/
myBinderRelated Content
-
Doctors Making Progress in Treating AmyloidosisAmyloidosis is a rare condition that use...
-
ISA 2020 | MRD Using Multi-Parametric Flow Cytometry in AL Amyloidosishttps://www.youtube.com/watch?v=hhOs8uTf...
-
ISA 2020 | Localized Amyloidosis: Symptoms and Site of Diseasehttps://www.youtube.com/watch?v=ogscp641...
-
Clinical Presentation, Diagnosis and Treatment of TTR AmyloidosisSystemic amyloidosis can be hereditary o...
-
Increasing Rate of Hospital Admissions in Patients with Amyloidosis (From the National Inpatient Sample)Cardiac amyloidosis is an increasingly...
-
Webinar Presentation by Jose Nativi-Nicolau on Light Chain Amyloidosis in the Hearthttps://www.youtube.com/watch?v=I1UQpBS5...
-
Julie L. Rosenthal, MDJulie L. Rosenthal is a Cardiologist-Int...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
